Article
APOE-specific Cognitive Effects of Levetiracetam in Mid-Age Adults
2026-05-21
Abstract excerpt
<h4>Background</h4> Low-dose levetiracetam is under investigation as a potential treatment for slowing Alzheimer’s Disease progression. This study tests whether levetiracetam enhances executive function in mid-age adults, and whether drug effects differ by Apolipoprotein e4 (APOE4+) genetic risk status. <h4>Methods</h4> Fifty-eight adults (aged 45-65 years; 27 APOE33; 31 APOE4+) participated in a double-blind, p...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- f4f44246-bbcc-501b-a5f6-3ba6ade13b12
- DOI
- 10.64898/2026.05.14.26352135
